GLP-1 medications were one of the hottest topics in healthcare in 2023, and interest in the weight-loss medications is only expected to increase, which will likely result in different approaches from leading companies
It was found that Alzheimers patients that were randomly assigned to the acetyl l-carnitine group (ingesting 2.5-3g daily) again had a slower rate of deterioration in a range of neuropsychological parameters
suggested that intravenous glutamine is not recommended in unstable patients undergoing a series of critical care procedures, especially those with liver and kidney failure, but may be considered for patients requiring exclusive parenteral nutrition
Find out what treatment is suitable for you with ZipHealth
One 2022 real-world analysis found that GLP-1 agonists maintained reasonable glycemic control in 6070% of patients on moderate-dose corticosteroids, though dose escalation was common
Online weight loss drug players have not shied away from marketing new compounded GLP-1 offerings